Search results for "adverse drug reaction"

showing 6 items of 36 documents

Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Usin…

2015

Drug-induced liver injury is a major problem of pharmacotherapy and is also frequent with antidepressive psychopharmacotherapy. However, there are only few studies using a consistent methodologic approach to study hepatotoxicity of a larger group of antidepress ants. We performed a quantitative signal detection analysis using data from the Uppsala Monitoring Centre from the WHO that records adverse drug reaction (ADR) data from worldwide sources; we retrieved substance- and country-specific (Australia, France, Germany, Italy, Spain, the United Kingdom, and the United States) ADR data and calculated reporting odds ratios as measures for disproportionality within a case/noncase approach. To a…

medicine.medical_specialtyInternationalityDatabases FactualMedDRAMirtazapineAmineptinePharmacology03 medical and health sciences0302 clinical medicineInternal medicinePharmacovigilancemedicineAgomelatineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)030212 general & internal medicinePharmacologybusiness.industryAustraliaOdds ratiomedicine.diseaseAntidepressive AgentsUnited StatesEuropeChemical and Drug Induced Liver InjuryNefazodonebusiness030217 neurology & neurosurgeryAdverse drug reactionmedicine.drugJournal of clinical pharmacology
researchProduct

Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report

2021

Background Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse drug reaction often presenting as a post-surgery complication that may interfere in the quality of the patient's life. In the last decade, additionally to bisphosphonates, other drugs have been associated with MRONJ including other antiresorptive, antiangiogenic or multitarget drugs such as levantinib. The data on MRONJ associated to lenvatinib is scarce with no guidelines for best management option. Our aim is to report a case of MRONJ associated with lenvatinib and the useful of a non-invasive management using local photobiomodulation (PBM) therapy with a 635nm diode laser. Material and methods A 61-year-o…

medicine.medical_specialtyPanoramic radiographOral Medicine and Pathologybusiness.industryCase Reportmedicine.diseaseSurgerychemistry.chemical_compoundQuality of lifechemistryMaxillamedicineComplicationLenvatinibOsteonecrosis of the jawbusinessGeneral DentistryOral medicineUNESCO:CIENCIAS MÉDICASAdverse drug reactionJournal of Clinical and Experimental Dentistry
researchProduct

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients

2013

Adverse drug reactions to highly antiretroviral therapy (HAART) are major obstacles in its success. Although overall mortality from HIV has dramatically declined owing to HAART, these antiretroviral regimens have been associated with a wide spectrum of severe cutaneous reactions. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. To optimize adherence and efficacy of antiretroviral treatment, clinicians must focus on preventing adverse effects whenever possible, and distinguish those that are self-limited from those that are potentially serious. This paper presents the case of a serious cutaneous adverse reaction to Atripla in a HIV-positive 50-…

medicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Adverse drug reactionAdverse drug reactionsHIVDermatologylcsh:RL1-803medicine.disease_causeAntiretroviral therapyPublished online: May 2014Surgerylcsh:DermatologymedicineAntiretroviral treatmentSettore MED/35 - Malattie Cutanee E VenereeDrug reactionIntensive care medicinebusinessAdverse effectHighly antiretroviral therapySkin
researchProduct

Oral Squamous Cell Carcinoma Mimicking Medication-Related Osteonecrosis of the Jaws (MRONJ): A Case Series

2021

(1) Background: Medication-related osteonecrosis of the jaw (MRONJ) is a potential adverse drug reaction of antiresorptive and/or antiangiogenic treatment. MRONJ is mostly diagnosed by anamnestic data, clinical examination and radiological findings, with signs and symptoms often unspecific. On the other hand, oral squamous cell carcinoma (OSCC) is characteristic for its pleomorphic appearance (e.g., ulcer, mucous dehiscence, non-healing post-extractive socket). We report three cases where OSCC mimicked MRONJ lesions. (2) Patients: Three patients undergoing amino-bisphosphonate treatment for osteoporosis presented with areas of intraorally exposed jawbone and unspecific radiological signs co…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryOsteoporosisONJPhysical examinationRK1-715Dehiscencemedicine.diseaseMRONJDermatologyOral Squamous Cell CarcinomaMedication-Related Osteonecrosis of the Jaws MRONJ Case Seriesoral squamous cell carcinomastomatognathic diseasesosteonecrosis of the jawRadiological weaponDentistrymedicinebone exposureIn patientBasal cellOSCCOsteonecrosis of the jawbusinessAdverse drug reaction
researchProduct

Painful oral aphthous-like lesions in patient with kidney cancer after target therapy and bisphosphonate administration: a case report of adverse dru…

2015

Aim. Tyrosine kinase inhibitors (TKIs) targeting tu- mor angiogenesis and mammalian target of rapamycin inhibitors (mTOR) are indicated for the management of several cancer types, as for renal cell carcinoma (RCC). Oral ulcerations are reported as common adverse drug reactions of mTOR inhibitors and are currently classified as mTOR inhibitor associated stomatitis (mIAS). Interestingly, these lesions appear as aphthous-like stoma- titis rather than the mucositis seen with chemotherapy agent. Case report. A 49 years old male patient underwent to the left radical nephrectomy in May 2014 for clear RCC. From July to October 2014 he was treated with Pazopanib, a tyrosine kinase inhibitor. In Dece…

oral aphthous-like target therapy bisphosphonate adverse drug reactionSettore MED/28 - Malattie Odontostomatologiche
researchProduct

THE ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTIRETROVIRAL THERAPY

2020

Over the last few years, the Hospital Pharmacy has developed in an excellent way in Europe, proposing in many countries the clinical pharmacist as a new professional figure, and adapting its responsibilities to national health systems. The purpose of this study is to evaluate and promote the prescriptive appropriateness through the close collaboration between the pharmacist and the medical team. The aspect of the dispensation of antiretroviral therapy was deepened by providing useful information to the patient on the possible undesired effects and interactions due to the polypharmacy, on the correct way of storing the drugs, and on the importance of the regularity of the polypharmacy intake…

pharmacovigilanceinteraction of antiretroviral drugsADRs (adverse drug reactions)Settore CHIM/08 - Chimica Farmaceuticaclinical pharmacistdrug therapy appropriateness
researchProduct